|
prostate gland morphogenesis
|
GO:0060512 |
1 |
0.642
|
|
|
secretion
|
GO:0046903 |
254 |
0.353
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.338
|
|
|
pharyngeal system development
|
GO:0060037 |
2 |
0.233
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.217
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.203
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.187
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.186
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.180
|
|
|
intracellular steroid hormone receptor signaling pathway
|
GO:0030518 |
61 |
0.175
|
|
|
regulation of hormone secretion
|
GO:0046883 |
57 |
0.171
|
|
|
water homeostasis
|
GO:0030104 |
14 |
0.165
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.157
|
|
|
endocrine process
|
GO:0050886 |
25 |
0.156
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.145
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.139
|
|
|
protein processing
|
GO:0016485 |
226 |
0.139
|
|
|
segmentation
|
GO:0035282 |
4 |
0.136
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.130
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.125
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.120
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.113
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.112
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.112
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.112
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.110
|
Mouse |
|
signal release
|
GO:0023061 |
70 |
0.109
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.108
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.107
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.104
|
|
|
detection of chemical stimulus involved in sensory perception
|
GO:0050907 |
33 |
0.101
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.099
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.097
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.096
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
181 |
0.096
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.094
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.094
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.092
|
|
|
system process
|
GO:0003008 |
349 |
0.092
|
|
|
androgen receptor signaling pathway
|
GO:0030521 |
34 |
0.092
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.089
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.089
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.089
|
|
|
sensory perception of taste
|
GO:0050909 |
36 |
0.088
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.087
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.086
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.086
|
|
|
sensory perception of bitter taste
|
GO:0050913 |
28 |
0.085
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.085
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.085
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.083
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.083
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.081
|
|
|
metanephros development
|
GO:0001656 |
16 |
0.081
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.078
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.078
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.077
|
|
|
response to drug
|
GO:0042493 |
81 |
0.077
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.077
|
|
|
negative regulation of insulin like growth factor receptor signaling pathway
|
GO:0043569 |
4 |
0.076
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.076
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.074
|
Human Mouse |
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.073
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.072
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.072
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.071
|
|
|
steroid hormone secretion
|
GO:0035929 |
8 |
0.069
|
|
|
cellular response to tumor necrosis factor
|
GO:0071356 |
63 |
0.068
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.067
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.067
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.066
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.065
|
|
|
mating
|
GO:0007618 |
1 |
0.065
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.064
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.064
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.062
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
6 |
0.062
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.062
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.061
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.061
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.061
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.061
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.061
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.060
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.060
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.059
|
|
|
response to testosterone
|
GO:0033574 |
1 |
0.059
|
|
|
kidney development
|
GO:0001822 |
53 |
0.058
|
|
|
lipid localization
|
GO:0010876 |
106 |
0.057
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.057
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.057
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.056
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.056
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.055
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.055
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.054
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.054
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.053
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.053
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.053
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.053
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.053
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.052
|
|
|
renal system development
|
GO:0072001 |
63 |
0.051
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.051
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.051
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.051
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
28 |
0.050
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.050
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.049
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.049
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.049
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.049
|
|
|
drinking behavior
|
GO:0042756 |
1 |
0.049
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
67 |
0.048
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.048
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.047
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.047
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
28 |
0.047
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.047
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.047
|
|
|
detection of stimulus
|
GO:0051606 |
85 |
0.047
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
48 |
0.046
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.046
|
|
|
endocrine hormone secretion
|
GO:0060986 |
13 |
0.046
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.045
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.045
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.045
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.045
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.045
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.045
|
|
|
steroid hormone mediated signaling pathway
|
GO:0043401 |
12 |
0.045
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.044
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.044
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.044
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.044
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.043
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.043
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.043
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.043
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.043
|
|
|
heart development
|
GO:0007507 |
95 |
0.042
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.042
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.041
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.041
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.041
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.041
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.040
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.039
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0006919 |
49 |
0.039
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.039
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.039
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.039
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
38 |
0.038
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.038
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.038
|
|
|
detection of chemical stimulus involved in sensory perception of taste
|
GO:0050912 |
31 |
0.038
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.038
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.037
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.037
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
25 |
0.036
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.036
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.036
|
|
|
regulation of estrogen receptor binding
|
GO:0071898 |
3 |
0.036
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.036
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.035
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.035
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.035
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.034
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.034
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.034
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.034
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.034
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.034
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.034
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.034
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.033
|
|
|
tube development
|
GO:0035295 |
125 |
0.033
|
Mouse |
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.033
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.033
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.032
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
155 |
0.032
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.032
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.032
|
|
|
response to ketone
|
GO:1901654 |
19 |
0.031
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.031
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.030
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
35 |
0.030
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.030
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.030
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.030
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.029
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.029
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.029
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
43 |
0.029
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
22 |
0.029
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.029
|
|
|
aorta development
|
GO:0035904 |
2 |
0.029
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.029
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.028
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.028
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.028
|
|
|
detection of stimulus involved in sensory perception
|
GO:0050906 |
43 |
0.028
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.027
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
23 |
0.027
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.027
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.027
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.027
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.027
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.026
|
|
|
cellular response to interleukin 1
|
GO:0071347 |
35 |
0.026
|
|
|
response to salt stress
|
GO:0009651 |
3 |
0.026
|
|
|
regulation of insulin like growth factor receptor signaling pathway
|
GO:0043567 |
8 |
0.026
|
|
|
cellular response to oxygen containing compound
|
GO:1901701 |
276 |
0.025
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.025
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.025
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.025
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.025
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.025
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.025
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.025
|
|
|
somite development
|
GO:0061053 |
7 |
0.025
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.024
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.024
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.024
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.024
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.024
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.024
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.023
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.023
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.023
|
|
|
immune response in mucosal associated lymphoid tissue
|
GO:0002386 |
1 |
0.023
|
|
|
organ formation
|
GO:0048645 |
3 |
0.023
|
|
|
negative regulation of estrogen receptor binding
|
GO:0071899 |
3 |
0.023
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.023
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
55 |
0.023
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
37 |
0.022
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.022
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.022
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.022
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.022
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.022
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.022
|
|
|
wound healing
|
GO:0042060 |
115 |
0.021
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.021
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.021
|
|
|
gland development
|
GO:0048732 |
48 |
0.021
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.021
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.021
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.021
|
|
|
negative regulation of protein binding
|
GO:0032091 |
35 |
0.021
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.021
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.021
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.020
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.020
|
|
|
regulation of lipid transport
|
GO:0032368 |
44 |
0.020
|
|
|
cation transport
|
GO:0006812 |
331 |
0.020
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.020
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.020
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.020
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.020
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.020
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.020
|
|
|
retina homeostasis
|
GO:0001895 |
42 |
0.020
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.019
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.019
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.019
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.019
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.019
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.019
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.019
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.019
|
|
|
cellular response to acid chemical
|
GO:0071229 |
44 |
0.019
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.019
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.019
|
|
|
midgut development
|
GO:0007494 |
1 |
0.019
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.018
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.018
|
|
|
regionalization
|
GO:0003002 |
29 |
0.018
|
|
|
skin development
|
GO:0043588 |
76 |
0.018
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.018
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.018
|
|
|
cell substrate adhesion
|
GO:0031589 |
132 |
0.018
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.018
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
37 |
0.018
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.018
|
Fly |
|
detection of chemical stimulus
|
GO:0009593 |
55 |
0.018
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.018
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.018
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
66 |
0.018
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
124 |
0.018
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.018
|
|
|
sensory perception of pain
|
GO:0019233 |
4 |
0.018
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.018
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.018
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.018
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.018
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.017
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.017
|
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.017
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.017
|
|
|
regulation of peptide secretion
|
GO:0002791 |
42 |
0.017
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.017
|
|
|
regulation of endocrine process
|
GO:0044060 |
12 |
0.017
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.017
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.017
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.017
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.017
|
|
|
monovalent inorganic cation homeostasis
|
GO:0055067 |
37 |
0.017
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.017
|
|
|
regulation of dephosphorylation
|
GO:0035303 |
96 |
0.017
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.017
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.017
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.017
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.017
|
|
|
defense response
|
GO:0006952 |
315 |
0.017
|
Human |
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.017
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.016
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.016
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.016
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.016
|
Mouse |
|
regulation of cell growth
|
GO:0001558 |
135 |
0.016
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.016
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
4 |
0.016
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.016
|
|
|
positive regulation of rac gtpase activity
|
GO:0032855 |
31 |
0.016
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.016
|
Fly |
|
regulation of growth
|
GO:0040008 |
165 |
0.016
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.016
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.016
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.016
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.016
|
|
|
detection of mechanical stimulus
|
GO:0050982 |
4 |
0.016
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.016
|
|
|
ribonucleoside monophosphate catabolic process
|
GO:0009158 |
158 |
0.015
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.015
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.015
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
159 |
0.015
|
|
|
immunoglobulin transcytosis in epithelial cells
|
GO:0002414 |
1 |
0.015
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.015
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.015
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.015
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.015
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.015
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.015
|
|
|
cell projection assembly
|
GO:0030031 |
126 |
0.015
|
|
|
leukocyte migration
|
GO:0050900 |
107 |
0.015
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
50 |
0.015
|
|
|
gland morphogenesis
|
GO:0022612 |
8 |
0.015
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.015
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.015
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.015
|
|
|
neural tube patterning
|
GO:0021532 |
2 |
0.015
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.015
|
|
|
acetate ester metabolic process
|
GO:1900619 |
3 |
0.014
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.014
|
|
|
menstruation
|
GO:0042703 |
1 |
0.014
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
93 |
0.014
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.014
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.014
|
|
|
embryo development
|
GO:0009790 |
123 |
0.014
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.014
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.014
|
|
|
regulation of phosphatase activity
|
GO:0010921 |
81 |
0.014
|
|
|
trabecula morphogenesis
|
GO:0061383 |
2 |
0.014
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.014
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.014
|
|
|
menstrual cycle phase
|
GO:0022601 |
2 |
0.014
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.014
|
|
|
cilium organization
|
GO:0044782 |
68 |
0.014
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.014
|
Mouse |
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.014
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.014
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.014
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.014
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.014
|
|
|
regulation of response to external stimulus
|
GO:0032101 |
222 |
0.014
|
|
|
male gonad development
|
GO:0008584 |
23 |
0.014
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.014
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.014
|
|
|
rhythmic behavior
|
GO:0007622 |
2 |
0.014
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.014
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.014
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.014
|
|
|
regulation of leukocyte activation
|
GO:0002694 |
115 |
0.014
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
22 |
0.013
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.013
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.013
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.013
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.013
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.013
|
|
|
negative regulation of extracellular matrix disassembly
|
GO:0010716 |
3 |
0.013
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.013
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.013
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
155 |
0.013
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.013
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.013
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.013
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.013
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.013
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.013
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.013
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.013
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.013
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.013
|
|
|
histone modification
|
GO:0016570 |
251 |
0.013
|
|
|
nucleic acid phosphodiester bond hydrolysis
|
GO:0090305 |
102 |
0.013
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.013
|
|
|
immune response
|
GO:0006955 |
307 |
0.013
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.013
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.013
|
|
|
cilium morphogenesis
|
GO:0060271 |
75 |
0.013
|
|
|
growth
|
GO:0040007 |
202 |
0.013
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.013
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.013
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.013
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.013
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.013
|
|
|
detection of mechanical stimulus involved in sensory perception
|
GO:0050974 |
1 |
0.013
|
|
|
cellular response to drug
|
GO:0035690 |
27 |
0.012
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.012
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.012
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.012
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.012
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.012
|
|
|
atp catabolic process
|
GO:0006200 |
157 |
0.012
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.012
|
|
|
regulation of eosinophil activation
|
GO:1902566 |
2 |
0.012
|
|
|
plasma membrane organization
|
GO:0007009 |
115 |
0.012
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
3 |
0.012
|
|
|
sodium ion homeostasis
|
GO:0055078 |
14 |
0.012
|
|
|
hard palate development
|
GO:0060022 |
1 |
0.012
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.012
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.012
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
124 |
0.012
|
|
|
dna repair
|
GO:0006281 |
198 |
0.012
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.012
|
|
|
cellular response to nitrogen compound
|
GO:1901699 |
144 |
0.012
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.012
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.012
|
|
|
mesenchymal to epithelial transition involved in metanephros morphogenesis
|
GO:0003337 |
4 |
0.012
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.012
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.012
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
73 |
0.012
|
|
|
memory
|
GO:0007613 |
3 |
0.012
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.012
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.012
|
|
|
negative regulation of mast cell activation involved in immune response
|
GO:0033007 |
1 |
0.012
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
14 |
0.012
|
|
|
viral life cycle
|
GO:0019058 |
132 |
0.012
|
|
|
phospholipid metabolic process
|
GO:0006644 |
99 |
0.012
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.012
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.012
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.012
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.012
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.011
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.011
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.011
|
|
|
thymus development
|
GO:0048538 |
3 |
0.011
|
|
|
regulation of actin filament length
|
GO:0030832 |
56 |
0.011
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.011
|
|
|
tissue migration
|
GO:0090130 |
119 |
0.011
|
|
|
gas transport
|
GO:0015669 |
3 |
0.011
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.011
|
|
|
eosinophil activation
|
GO:0043307 |
3 |
0.011
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.011
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.011
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.011
|
|
|
potassium ion transport
|
GO:0006813 |
62 |
0.011
|
|
|
negative regulation of icosanoid secretion
|
GO:0032304 |
2 |
0.011
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.011
|
|
|
developmental process involved in reproduction
|
GO:0003006 |
66 |
0.011
|
|
|
embryonic placenta development
|
GO:0001892 |
1 |
0.011
|
|
|
regulation of protein polymerization
|
GO:0032271 |
63 |
0.011
|
|
|
negative regulation of eosinophil activation
|
GO:1902567 |
1 |
0.011
|
|
|
epithelial tube branching involved in lung morphogenesis
|
GO:0060441 |
4 |
0.011
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
41 |
0.011
|
|
|
copulation
|
GO:0007620 |
1 |
0.011
|
|
|
negative regulation of leukocyte migration
|
GO:0002686 |
14 |
0.011
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.011
|
|